Savara, Inc. (SVRA)
5.53
-0.19
(-3.32%)
USD |
NASDAQ |
Feb 20, 16:00
5.60
+0.07
(+1.27%)
After-Hours: 20:00
Savara SG&A Expense (Quarterly) : 9.627M for Sept. 30, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| ADMA Biologics, Inc. | 23.05M |
| ACADIA Pharmaceuticals, Inc. | 133.40M |
| Alnylam Pharmaceuticals, Inc. | 325.37M |
| BioMarin Pharmaceutical, Inc. | 268.40M |
| Imunon, Inc. | 1.577M |